88 related articles for article (PubMed ID: 26500167)
1. Prognostication by inflammation-based score in patients with locally advanced pancreatic cancer treated with chemoradiotherapy.
Kurahara H; Maemura K; Mataki Y; Sakoda M; Iino S; Hiwatashi K; Kawasaki Y; Arigami T; Ishigami S; Kijima Y; Shinchi H; Takao S; Natsugoe S
Pancreatology; 2015; 15(6):688-93. PubMed ID: 26500167
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer.
Chadha AS; Kocak-Uzel E; Das P; Minsky BD; Delclos ME; Mahmood U; Guha S; Ahmad M; Varadhachary GR; Javle M; Katz MH; Fleming JB; Wolff RA; Crane CH; Krishnan S
Acta Oncol; 2015 Jul; 54(7):971-8. PubMed ID: 25608822
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Glasgow Prognostic Score in patients receiving chemoradiotherapy for stage III and IV esophageal cancer.
Kimura J; Kunisaki C; Makino H; Oshima T; Ota M; Oba M; Takagawa R; Kosaka T; Ono HA; Akiyama H; Endo I
Dis Esophagus; 2016 Nov; 29(8):1071-1080. PubMed ID: 26471766
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.
Sher DJ; Gielda BT; Liptay MJ; Warren WH; Batus M; Fidler MJ; Garg S; Bonomi P
Clin Lung Cancer; 2013 Jul; 14(4):370-5. PubMed ID: 23260389
[TBL] [Abstract][Full Text] [Related]
5. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer.
Geng Y; Qi Q; Sun M; Chen H; Wang P; Chen Z
Eur J Surg Oncol; 2015 Nov; 41(11):1508-14. PubMed ID: 26343824
[TBL] [Abstract][Full Text] [Related]
6. Glasgow prognostic score predicts therapeutic outcome after pancreaticoduodenectomy for carcinoma of the ampulla of vater.
Shiba H; Misawa T; Fujiwara Y; Futagawa Y; Furukawa K; Haruki K; Iwase R; Wakiyama S; Ishida Y; Yanaga K
Anticancer Res; 2013 Jun; 33(6):2715-21. PubMed ID: 23749931
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer.
Kishi T; Nakamura A; Itasaka S; Shibuya K; Matsumoto S; Kanai M; Kodama Y; Takaori K; Mizowaki T; Hiraoka M
Pancreatology; 2015; 15(6):694-700. PubMed ID: 26601881
[TBL] [Abstract][Full Text] [Related]
8. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.
Huguet F; André T; Hammel P; Artru P; Balosso J; Selle F; Deniaud-Alexandre E; Ruszniewski P; Touboul E; Labianca R; de Gramont A; Louvet C
J Clin Oncol; 2007 Jan; 25(3):326-31. PubMed ID: 17235048
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients.
Ichikawa K; Mizuno S; Hayasaki A; Kishiwada M; Fujii T; Iizawa Y; Kato H; Tanemura A; Murata Y; Azumi Y; Kuriyama N; Usui M; Sakurai H; Isaji S
Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30974894
[No Abstract] [Full Text] [Related]
10. ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer.
Watanabe T; Ueno H; Watabe Y; Hiraoka N; Morizane C; Itami J; Okusaka T; Miura N; Kakizaki T; Kakuya T; Kamita M; Tsuchida A; Nagakawa Y; Wilber H; Yamada T; Honda K
Br J Cancer; 2015 Feb; 112(4):704-13. PubMed ID: 25602965
[TBL] [Abstract][Full Text] [Related]
11. Hyperfibrinogen Is Associated With the Systemic Inflammatory Response and Predicts Poor Prognosis in Advanced Pancreatic Cancer.
Qi Q; Geng Y; Sun M; Chen H; Wang P; Chen Z
Pancreas; 2015 Aug; 44(6):977-82. PubMed ID: 25931258
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapy.
Kim SS; Lee S; Lee HS; Bang S; Park MS
Abdom Radiol (NY); 2021 Feb; 46(2):655-666. PubMed ID: 32748250
[TBL] [Abstract][Full Text] [Related]
13. A Novel Scoring System Based on Fibrinogen and the Neutrophil-Lymphocyte Ratio as a Predictor of Chemotherapy Response and Prognosis in Patients with Advanced Gastric Cancer.
Arigami T; Uenosono Y; Ishigami S; Okubo K; Kijima T; Yanagita S; Okumura H; Uchikado Y; Kijima Y; Nakajo A; Kurahara H; Kita Y; Mori S; Maemura K; Natsugoe S
Oncology; 2016; 90(4):186-92. PubMed ID: 26981856
[TBL] [Abstract][Full Text] [Related]
14. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?
Papalezova KT; Tyler DS; Blazer DG; Clary BM; Czito BG; Hurwitz HI; Uronis HE; Pappas TN; Willett CG; White RR
J Surg Oncol; 2012 Jul; 106(1):111-8. PubMed ID: 22311829
[TBL] [Abstract][Full Text] [Related]
15. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX
Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228
[TBL] [Abstract][Full Text] [Related]
16. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
[TBL] [Abstract][Full Text] [Related]
17. The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancer.
Wang H; Gao J; Bai M; Liu R; Li H; Deng T; Zhou L; Han R; Ge S; Huang D; Ba Y
Platelets; 2014; 25(5):382-7. PubMed ID: 24001199
[TBL] [Abstract][Full Text] [Related]
18. Human equilibrative nucleoside transporter 1 expression is a strong independent prognostic factor in UICC T3-T4 pancreatic cancer patients treated with preoperative gemcitabine-based chemoradiotherapy.
Murata Y; Hamada T; Kishiwada M; Ohsawa I; Mizuno S; Usui M; Sakurai H; Tabata M; Ii N; Inoue H; Shiraishi T; Isaji S
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):413-25. PubMed ID: 21898089
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact of Pretreatment Plasma Fibrinogen in Patients with Locally Advanced Oral and Oropharyngeal Cancer.
Holzinger D; Danilovic I; Seemann R; Kornek G; Engelmann J; Pillerstorff R; Holawe S; Psyrri A; Erovic BM; Farwell G; Perisanidis C
PLoS One; 2016; 11(6):e0158697. PubMed ID: 27362659
[TBL] [Abstract][Full Text] [Related]
20. Serum ferritin predicted prognosis in patients with locally advanced pancreatic cancer.
Wang SL; Cao S; Wu R; Chi F; Tang MY; Jin XY; Chen XD
Future Oncol; 2015; 11(21):2905-10. PubMed ID: 26436474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
